propafenone has been researched along with Hibernation, Myocardial in 3 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied left atrial function in 55 patients undergoing electrical (n = 23) or chemical (intravenous administration of propafenone, n = 32) attempts at cardioversion from atrial fibrillation." | 7.70 | Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation. ( Antonielli, E; Baralis, G; Bassignana, A; Di Leo, M; Pizzuti, A; Rovere, ME; Tanga, M, 1999) |
| "We studied left atrial function in 55 patients undergoing electrical (n = 23) or chemical (intravenous administration of propafenone, n = 32) attempts at cardioversion from atrial fibrillation." | 3.70 | Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation. ( Antonielli, E; Baralis, G; Bassignana, A; Di Leo, M; Pizzuti, A; Rovere, ME; Tanga, M, 1999) |
| "Forty patients with paroxysmal atrial fibrillation (20 females, 20 males), aged 60-83 (mean 72." | 2.71 | Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation. ( Wysokiński, A; Zapolski, T, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zapolski, T | 1 |
| Wysokiński, A | 1 |
| Ciolli, A | 1 |
| De Sisti, A | 1 |
| Montenero, AS | 1 |
| Sanna, T | 1 |
| Lo Sardo, G | 1 |
| Palamara, A | 1 |
| Antonielli, E | 1 |
| Pizzuti, A | 1 |
| Bassignana, A | 1 |
| Tanga, M | 1 |
| Baralis, G | 1 |
| Rovere, ME | 1 |
| Di Leo, M | 1 |
1 trial available for propafenone and Hibernation, Myocardial
| Article | Year |
|---|---|
Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function, L | 2005 |
2 other studies available for propafenone and Hibernation, Myocardial
| Article | Year |
|---|---|
[Idiopathic atrial fibrillation of recent onset and atrial stunning: the echocardiographic evidence after pharmacological cardioversion].
Topics: Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography, Do | 1998 |
Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Flow Velocity; Echocardiography, Dop | 1999 |